ComputerWeekly

Interview: Loïc Giraud, vice-president of data and AI foundation, Novo


After spending time at a startup, Loïc Giraud, vice-president of the data and artificial intelligence (AI) foundation at healthcare and pharmaceutical company Novo, returned to what he knows best just over two years ago – helping a blue-chip enterprise exploit its information assets.

Computer Weekly last spoke with Giraud in May 2022, when he was global head of digital platform and product delivery at Novartis, where he managed a data-led digital transformation programme across the healthcare specialist. After more than 11 years with Novartis, he spent 12 months in the startup sector as chief operating officer at AI technology specialist Calibo.

“When you’re running a startup in the early phase, you have to do a lot of sales and marketing, which is probably not my core competence,” he says, reflecting on the entrepreneurial experience. “I realised I wanted to go back to enterprise. I came to Novo to lead the data and AI function. I’ve been doing that since August 2024.”

Giraud describes his past two years at Novo as a rollercoaster. He’s had to make tough choices to help the organisation embrace emerging technologies. From data platforms to agentic services, his team has built the foundations to help the business grow. Looking back on the transformations they’ve enabled, Giraud recognises it’s been an interesting ride.

“They recruited me because they were not successful in bringing data and the AI function together,” he says. “That was my remit when I joined. I think we have a clear perspective on how we can become the most AI-driven healthcare company in the world, and how we drive patient acquisition and patient adherence, and treat their needs effectively.”

Providing capabilities

Giraud joined a team with decentralised activities that lacked clear focus on business priorities and strategic ambitions. While some teams did good work, he was eager to bring more structure to data operations.

“It took me a bit of time to understand how everything functioned,” he says. “We had to focus on explaining to stakeholders, trying to change the operating model and the incentives, and then we started to build trust by creating products that bring value while trying to develop capabilities that help you for the long term.”

Giraud says his team has made considerable progress since 2024. During this time, emerging technology has begun to play a bigger role in business operations. As more people across business functions have started exploring AI-enabled services, the emphasis has shifted.

“That’s a big paradigm shift in the industry,” he says. “There used to be a lot of central software engineers and AI engineers, and then technology became so simple that you’re now more or less becoming an orchestrator and enabler, and then you decentralise the execution.”

Today, Giraud describes his role at Novo as establishing AI and data strategy: “How do you align that with the business priorities across the respective business domains? How do you execute that through a portfolio of products, as well as building the right platform capability that helps you to scale?”

Giraud says orchestration and enablement involve establishing the platforms and processes that allow professionals to build their own solutions to business challenges. “You have to provide the capabilities in which they can be self-sufficient, and then the guardrails and controls,” he adds.

“And I would say 80% of our time is focused on that area. The remaining 20% is building complex solutions or helping the business identify problems that need solutions. We think about those problems to the point that a future product line can be established.”

Empowering and automating

Giraud says the general direction of the firm’s digital transformation is about creating data-enabled healthcare solutions for customers. His team’s efforts centre on three areas: empowerment, automation, and reinvention.

“With empowerment specifically, how do you provide the digital fluency for your end-users to be able to actually perform the work differently?” he says. “So, technically, training and the tools are required for them to be assisted and then to be more creative, and to spend less time on routine work and then be more focused on innovation.”

Emerging technology plays a crucial role in empowerment. Giraud says more than 60% of Novo employees now use AI every week. The data team has helped establish ChatGPT as the company’s conversational front-end user interface. They’re building connections so users can chat to data in key systems, such as the firm’s Snowflake data platform.

For automation, the data team considers how emerging technologies such as agentic AI can reimagine business process workflows.

“You can eliminate a lot of steps and use agents to perform many of these tasks, and sometimes you have to differentiate between what humans need to do versus what the agents need to do – and this is a core of our business,” says Giraud.

He adds that this reimagination is a work in progress. The business has identified where agents can automate certain workflows and is exploring how AI is used across key lines of business, including human resources and procurement processes. The company has almost 8,000 agents in production, including for productivity and research and development.

While the progress in automation is impressive, Giraud says he wouldn’t describe Novo as an agentic business: “No, I would not say we are at that stage yet. It will probably take another two years to get there. I must say that compared to last year, when we had none, I think we are quite far right now.”

Centralising data services

One key area of progress is the firm’s Snowflake data platform. The implementation pre-dated Giraud’s arrival, but he’s continued to hone the deployment since joining Novo, including working with the technology specialist to support agentic explorations.

“Snowflake has been established mostly in the commercial space,” he says. “All our affiliates use the same platform for their commercial activities, so it’s the only platform sales and marketing use. When I joined, the platform was decentralised. We had different Snowflake teams globally. We centralised that approach into one single function.”

The company’s corporate affiliates and subsidiaries across 80 countries use the platform for operational activities, including sales, marketing, finance, and procurement. Around 25,000 people in the affiliates use the platform directly or indirectly. With more than 900TB of data in Snowflake, Novo is using the scalable cloud-based platform to feed agentic systems.

“Every company must reinvent itself continually”

Loïc Giraud, Novo

Giraud says the company uses the personal productivity agent Snowflake CoWork to help professionals query data. Novo staff can use CoWork to ask questions in natural language and to access information that helps them position the right drugs to patients. The agent also helps the company to translate product information across its affiliates.

“It’s mostly around consumer understanding and portfolio management,” he says, referring to the use of the Snowflake platform and CoWork. “The technology provides the information to support the field force. The intent is to help our field reps prepare for their visits to the healthcare providers, whether they have a voice interaction or use a chat interface.”

Novo is also exploring CoCo, Snowflake’s coding agent that assists professionals with machine learning workflows. Giraud says data engineers are building new connections to services with the agent.

“They’re increasing the depth in the stack,” he says, reflecting on Snowflake’s recent product developments, which Computer Weekly saw first-hand in San Francisco. “They’ve completely revamped their strategy and how they position and drive the AI agenda.”

Reinventing the business

The final area of Novo’s digital transformation focuses on reinvention – and Giraud suggests this is a key component as the firm continues to grow. The business has grown by almost 20% annually during the past four years and aims to reach 60 million patients by 2030.

“Every company must reinvent itself continually,” he says, reflecting on the rapid pace of change in the AI age.

One key area of innovation is drug discovery. Novo’s US patent for semaglutide, the main ingredient in its Wegovy and Ozempic weight-loss drugs, is set to expire in 2032.

“We need to find the next generation of drugs,” he says. “Now, with frontier AI and access to IT infrastructure you never had before, you can do things much faster.”

Another key area of reinvention is consumerisation. Novo CEO Mike Doustdar said recently that the rapid growth of obesity treatments has transformed the firm’s patient base and shifted the market toward a more consumer-oriented model, where patients move on and off therapies more frequently than in traditional diabetes care.

Giraud recognises that his team can help Novo meet customers’ fast-changing requirements, including through product and service developments.

“We have an advanced digital innovation engine in research that helps us to identify a lot of potential targets that we are putting into execution,” he says, suggesting the engine is powered by frontier AI models.

“For consumerisation, we’ve launched our Novocare pharmacy service. It’s our front door for consumers to buy our products. We’ve also built a supporting data ecosystem in which we can better understand consumer needs and then activate that demand accordingly.”

Inside and outside the organisation, Giraud suggests the pace of change has never been quicker. He says the past two years have seen the most radical transformations witnessed during his 25-year career. However, this period of change is just the beginning. He expects significant disruption in the pharma industry during the next decade. Professionals must prepare for this continual transformation.

“What I can see right now is mind-blowing,” he says. “I’m more worried for the new generation of workers because they will have to be much more agile and adaptable than we have been. That’s probably my advice for any of these professionals – start to learn with AI and continue to be adaptable to change.”



Source link